GRIFOLS | GRF - Umlaufvermögen

Aktienkurs
9.18
Täglich Wechseln
0.38 4.27%
Monatlich
-2.82%
Jährlich
6.65%
Q2 Prognose
8.71




Umlaufvermögen Veränderung Datum
Alcon AG USD 6.62B 171M 2026-03
Almirall EUR 713.98M 69K 2025-12
Amadeus IT EUR 2.32B 162.6M 2026-03
Amarin USD 626.02M 23.87M 2026-03
argenx SE USD 6.9B 1.07B 2025-12
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Cie Automotive EUR 1.8B 6.22M 2025-12
Demant DKK 10.08B 128M 2025-12
Ence Energia y Celulosa EUR 387.33M 51.77M 2025-12
Essilor EUR 12.01B 981M 2025-12
Ferrovial EUR 7.31B 1.67B 2025-12
Fresenius EUR 11.03B 1.03B 2025-12
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Inditex EUR 15.69B 1.79B 2025-12
Lakefront Biotherapeutics EUR 3.06B 18.72M 2026-03
Merck EUR 13.23B 354M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Philips EUR 9.78B 148M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Smith & Nephew USD 4.63B 169M 2025-12
UCB EUR 6.05B 733M 2025-12
Viscofan EUR 854.65M 73.14M 2026-03